Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Total Liabilities (2023 - 2025)

Metagenomi (MGX) has disclosed Total Liabilities for 3 consecutive years, with $62.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 30.35% to $62.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $62.5 million, a 30.35% decrease, with the full-year FY2025 number at $62.5 million, down 30.35% from a year prior.
  • Total Liabilities was $62.5 million for Q4 2025 at Metagenomi, down from $69.5 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $149.7 million in Q4 2023 to a low of $119021.0 in Q3 2023.
  • A 3-year average of $90.4 million and a median of $89.9 million in 2023 define the central range for Total Liabilities.
  • Biggest YoY gain for Total Liabilities was 86082.27% in 2024; the steepest drop was 40.04% in 2024.
  • Metagenomi's Total Liabilities stood at $149.7 million in 2023, then tumbled by 40.04% to $89.7 million in 2024, then tumbled by 30.35% to $62.5 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Total Liabilities are $62.5 million (Q4 2025), $69.5 million (Q3 2025), and $76.5 million (Q2 2025).